戻る Agenda
Session 4C: Identification of Medicinal Products (IDMP)- Updates and Implementation Approaches
Session Chair(s)
Maggie Graham
Senior Policy Analyst, Natural and Non-Prescription Health Products Directorate, Health Canada, Canada
The ISO IDMP standard, and the European implementation of it, present a number of challenges in terms of the data that must be collected, managed, and submitted to the agencies. Explore how companies can – and should already be starting to – approach IDMP implmentation. Speakers will address how to design new processes for handling IDMP requirements and how to react to evolving requirements.
Speaker(s)
Donald Palmer, MA
Consultant, United States
Session Co-Chair
Joel Finkle
Industry Expert, Retired, United States
IDMP: Incrememental Data, More Processes
Vikesh Srivastava
Associate Director, Business Informatics Division, HPFB, Health Canada, Canada
IDMP Overview and a Regulators Perspective
Brooke Casselberry, MS, RAC
Vice President, Advisory and Delivery, Epista Life Science, United States
Industry Perception and Action on IDMP Standards: US and EU